SEAD™ (abnormal uterine bleeding)

The SEAD™ has the potential of becoming a strong and attractive choice 

of therapy in the worldwide GEA market through its simplicity,

cost-effectiveness and new and innovative yet gentle “substance-based Ablation” technology.



OM-80 is based on the proprietary IUB™ platform and is currently in concept development.